Yongin, South Korea

Young Doug Sohn

This inventor holds 1 USPTO granted patent. Top assignee: Biobud Co., Ltd.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young Doug Sohn. Retrieved from https://idiyas.com/inventor/young-doug-sohn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Young Doug Sohn: Innovator in Hyperproliferative Disorder Treatments**

Introduction

Young Doug Sohn is an accomplished inventor based in Yongin-si, South Korea. With a focus on medical innovations, he has developed significant advancements in the treatment of hyperproliferative vascular disorders and cancers. His contributions are particularly noteworthy given the increasing prevalence of these conditions in modern society.

Latest Patents

Young Doug Sohn holds one patent titled "Compositions for treating hyperproliferative vascular disorders and cancers." This invention relates to a method for treating or reducing the development of hyperproliferative disorders by administering a specific composition to a subject. His work represents a vital step in the quest for effective treatments in the medical field.

Career Highlights

Sohn's career has been marked by dedication to research and innovation. His role at Biobud Co., Ltd. has provided him the platform to apply his insights and engineering to real-world medical challenges. His notable invention underscores his commitment to improving patient outcomes and advancing healthcare technologies.

Collaborations

Throughout his career, Young Doug Sohn has collaborated with esteemed colleagues, including Kwang Hoe Chung and Chwang Siek Pak. These partnerships reflect a necessary synergy between different experts, enhancing the development of innovative therapies and expanding the impact of his research.

Conclusion

In conclusion, Young Doug Sohn exemplifies the spirit of innovation in the medical field, particularly in combating hyperproliferative disorders. His patent demonstrates a significant advancement in treatment options, and his collaborative efforts further elevate the importance of teamwork in research and development. As he continues his work at Biobud Co., Ltd., the future holds promising potential for his contributions to healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…